logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
M

Michael J. DiStefano

university of colorado anschutz medical campus

15H指数
84论文数
1.2K被引数
收录论文 30
发表时间
logo
Factors for Assessing Employment-Based Risks of Participation in Psychedelic Research参与致幻剂研究的就业风险评估因素
errAmerican Journal of Bioethics
IF20.8
err2026-09-18
err0
PREAI
errRachel J. Topazian; Michael J. DiStefano; Gianna Morales; Matthew DeCamp
err分享
err收藏
Does conventional cost-effectiveness analysis disadvantage treatments for severe disease? Evidence from U.S. value assessments传统成本效益分析是否不利于严重疾病的治疗？——来自美国价值评估的证据
errValue in Health
IF6
err2026-09-08
err0
PREAI
errAntal T. Zemplenyi; R. Brett McQueen; Harry Gyimah Gyamfi; Deepika Paratane; Michael J. DiStefano
err分享
err收藏
Integrating ethical analysis in health technology assessment: opportunities and challenges将伦理分析融入卫生技术评估：机遇与挑战
errInternational Journal of Technology Assessment in Health Care
IF3.1
err2026-05-21
err0
errOAAI
errBart Bloemen; Renata Axler; Michael J. DiStefano; Wija Oortwijn; Dario Sacchini; Michal Stanak; Duncan Steele; Gert Jan van der Wilt; Pietro Refolo
err分享
err收藏
Patient Preferences for Dementia Interventions: A Scoping Review With a Systematic Review of Medications and Choice-Based Methods痴呆干预措施的患者偏好：一项范围综述，包含对药物和基于选择方法的系统综述
errJOURNAL OF THE AMERICAN GERIATRICS SOCIETY
IF4.5
err2025-11-01
err0
PREAI
errGupta, Ravi; Lin, Shanshan; Distefano, Michael J.; Woo, Hyun Yi (jacqualine); Mao, Emily; Wilson, Renee; Amjad, Halima; Drabo, Emmanuel F.; Segal, Jodi B.
err分享
err收藏
Opportunities for CMS to Further Specify and Broaden Its Approach to Assessing Unmet Medical Need in the Context of the Medicare Drug Price Negotiation ProgramCMS在Medicare药品价格谈判计划背景下进一步明确和拓宽其评估未满足医疗需求方法的机遇
errApplied Health Economics and Health Policy
IF3.3
err2025-10-10
err0
PREAI
errMichael J. DiStefano; R. Brett McQueen; Hanke Zheng; Harry Gyimah Gyamfi; David Ameyaw; Jonathan D. Campbell; Antal Zemplenyi
err分享
err收藏
“The Crux of the Community”: A Qualitative Focus Group Study of the Impact of Community Pharmacy Closures in Colorado and Utah《社区的核心》：一项关于科罗拉多州和犹他州社区药房关闭影响的定性焦点小组研究
errJournal of the American Pharmacists Association
IF2.5
err2025-10-08
err0
errOAAI
errMichael J. DiStefano; Nai-Chia Chen; Carl V. Asche; Kelly E. Anderson; T.Joseph Mattingly
err分享
err收藏
Key Considerations for Assessing Real-World Comparative Effectiveness in the Context of the Drug Price Negotiation Program: A Case Study of Pembrolizumab药物价格谈判计划背景下评估真实世界比较有效性的关键考量：帕博利珠单抗案例研究
errPharmacoEconomics
IF4.6
err2025-06-23
err0
errOAAI
errAntal T. Zemplenyi; Nai-Chia Chen; Kelly E. Anderson; Blythe Adamson; Michael J. DiStefano; Kavita V. Nair; Robert B. McQueen
err分享
err收藏
Innovative Payment Models for Sickle-Cell Disease Gene Therapies in Medicaid: Leveraging Real-World Data and Insights from CMMI's Gene Therapy Access Model医疗补助计划中镰状细胞病基因疗法的创新支付模式：利用真实世界数据及CMMI基因疗法可及性模式的见解
errPHARMACOECONOMICS
IF4.6
err2025-02-21
err0
errOAAI
errZemplenyi, Antal; Leonard, Jim; Wright, Garth C.; Distefano, Michael J.; Nair, Kavita; Anderson, Kelly E.; Mcqueen, R. Brett
err分享
err收藏
Compounded glucagon-like peptide-1 receptor agonists for weight loss: the direct-to-consumer market in Colorado用于减肥的复合胰高血糖素样肽-1受体激动剂: 科罗拉多州的直接面向消费者的市场
errJOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE
IF2.5
err2024-12-24
err0
errOAAI
errDistefano, Michael J.; Dardouri, Mouna; Moore, Gina D.; Saseen, Joseph J.; Nair, Kavita V.
err分享
err收藏
The Cost of Continuous Glucose Monitoring Versus Self-Monitoring of Blood Glucose in Type 1 Diabetes Pregnancies in the United States: A Cost-Consequences Analysis Using Real-World Evidence
errDIABETES TECHNOLOGY & THERAPEUTICS
IF6.3
err2024-12-19
err0
PREAI
errDistefano, Michael J.; Mcqueen, R. Brett; Gao, Valerie; Klein, Matthew P.; Snell-Bergeon, Janet K.; Polsky, Sarit
err分享
err收藏
Pharmacy Closures and Anticonvulsant Medication Prescription Fills
errJAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
IF55
err2024-12-03
err0
PREAI
errAnderson, Kelly E.; Sahu, Maitreyi; DiStefano, Michael J.; Asche, Carl V.; Mattingly II, T. Joseph
err分享
err收藏
How Do the Institute for Clinical and Economic Review's Assessments of Comparative Effectiveness Compare With the German Federal Joint Committee's Assessments of Added Benefit? A Qualitative Study
errVALUE IN HEALTH
IF6
err2024-08-01
err0
PREAI
errDistefano, Michael J.; Pearson, Steven D.; Rind, David M.; Zemplenyi, Antal
err分享
err收藏
Cost of Continuous Glucose Monitoring vs. SelfMonitoring of Blood Glucose in Type 1 Diabetes Pregnancies
errDIABETES
IF7.5
err2024-06-14
err0
PREAI
errDistefano, Michael J.; McQueen, R. Brett; Gao, Valerie; Snell-Bergeon, Janet K.; Johnson, Carly A.; Klein, Matthew P.; Polsky, Sarit
err分享
err收藏
An empirical ethics study of the coherence of NICE technology appraisal policy and its implications for moral justification
errBMC MEDICAL ETHICS
IF3.1
err2024-03-06
err2
errOAAI
errCharlton, Victoria; Distefano, Michael
err分享
err收藏
The ethical canary: narrow reflective equilibrium as a source of moral justification in healthcare priority-setting
errJOURNAL OF MEDICAL ETHICS
IF3.4
err2024-02-19
err1
errOAAI
errCharlton, Victoria; DiStefano, Michael J.
err分享
err收藏
Estimated Savings From Using Added Therapeutic Benefit and Therapeutic Reference Pricing in United States Medicare Drug Price Negotiations在美国医疗保险药品价格谈判中使用额外的治疗益处和治疗参考定价带来的估计节省
errVALUE IN HEALTH
IF6
err2023-11-01
err4
errOAAI
errDistefano, Michael J.; Levy, Joseph F.; Odouard, Ilina C.; Anderson, Gerard F.
err分享
err收藏
We need to talk about values: a proposed framework for the articulation of normative reasoning in health technology assessment我们需要谈论价值: 在卫生技术评估中阐明规范推理的拟议框架
errhealth economics
IF3.3
err2023-09-27
err9
errOAAI
errCharlton, Victoria; Distefano, Michael; Mitchell, Polly; Morrell, Liz; Rand, Leah; Badano, Gabriele; Baker, Rachel; Calnan, Michael; Chalkidou, Kalipso; Culyer, Anthony; Howdon, Daniel; Hughes, Dyfrig; Lomas, James; Max, Catherine; Mccabe, Christopher; O'Mahony, James F.; Paulden, Mike; Pemberton-Whiteley, Zack; Rid, Annette; Scuffham, Paul; Sculpher, Mark; Shah, Koonal; Weale, Albert; Wester, Gry
err分享
err收藏
Incorporating Added Therapeutic Benefit and Domestic Reference Pricing Into Medicare Payment for Expensive Part B Drugs
errVALUE IN HEALTH
IF6
err2023-09-01
err0
errOAAI
errAnderson, Kelly E.; Distefano, Michael J.; Liu, Angela; Mattingly II, T. Joseph; Socal, Mariana P.; Anderson, Gerard F.
err分享
err收藏
Comparison of Out-of-Pocket Spending on Ultra-Expensive Drugs in Medicare Part D vs Commercial Insurance
errJAMA HEALTH FORUM
IF11.3
err2023-05-26
err7
errOAAI
errDiStefano, Michael J.; Kang, So-Yeon; Parasrampuria, Sonal; Anderson, Gerard F.
err分享
err收藏
Association Between Drug Characteristics and Manufacturer Spending on Direct-to-Consumer Advertising
errJAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
IF55
err2023-02-07
err7
errOAAI
errDiStefano, Michael J.; Markell, Jenny M.; Doherty, Caroline C.; Alexander, G. Caleb; Anderson, Gerard F.
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
S
Stephen W. Marshall
H 指数: 98 · 论文数: 814
M
Mark Sculpher
H 指数: 94 · 论文数: 645
G
G. Caleb Alexander
H 指数: 75 · 论文数: 506
G
Gerard F. Anderson
H 指数: 72 · 论文数: 444
J
Jodi B Segal
H 指数: 70 · 论文数: 555
查看更多